Abi-2 Activators
Abi-2 Activators belong to a specialized class of molecules with a unique role in cellular processes, particularly in the context of signal transduction and cytoskeletal regulation. Abi-2, short for Abl interactor 2, is a protein that plays a crucial role in the organization of the actin cytoskeleton, which is essential for maintaining cell shape, motility, and intracellular transport. Abi-2 itself does not possess enzymatic activity but functions as an adaptor protein that forms complexes with various other signaling molecules. Abi-2 Activators are compounds or proteins that enhance the activity of Abi-2, thereby influencing downstream cellular processes.
Abi-2 Activators are of significant interest in cell biology and molecular research due to their role in modulating actin dynamics. When activated, Abi-2 interacts with proteins such as N-WASP (Neural Wiskott-Aldrich Syndrome Protein) and WAVE (WASP-family Verprolin-homologous protein), leading to the activation of the Arp2/3 complex. This activation, in turn, promotes the nucleation and branching of actin filaments, allowing for the formation of lamellipodia and filopodia, which are crucial for processes like cell migration and adhesion. Additionally, Abi-2 Activators have been studied in the context of neuronal development, where they contribute to the regulation of dendritic spine morphology and synaptic plasticity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib is a tyrosine kinase inhibitor that can block the activity of tyrosine kinases, including Abl kinase. Inhibition of Abl kinase can lead to the dephosphorylation and activation of Abi-2, indirectly increasing its activity in actin cytoskeleton regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another inhibitor of the PI3K signaling pathway. Similar to LY294002, Wortmannin can influence the downstream signaling events involving Abi-2 by blocking PI3K activity. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib is an inhibitor of receptor tyrosine kinases (RTKs). By inhibiting RTKs, Gefitinib can modulate signaling pathways that may include Abi-2, potentially increasing its activity. | ||||||
PF 4708671 | 1255517-76-0 | sc-361288 sc-361288A | 10 mg 50 mg | $179.00 $700.00 | 9 | |
PF-3758309 is a protein kinase inhibitor that can target PAK kinases. Inhibition of PAK kinases may impact the downstream signaling pathways associated with Abi-2, potentially increasing its activity within the cell. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a compound that increases intracellular cAMP levels, acting as a secondary messenger. Elevated cAMP levels can influence various signaling cascades, which could indirectly increase Abi-2 activity. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a calcium chelator that can alter intracellular calcium levels, influencing calcium-dependent signaling pathways. Changes in calcium signaling may increase Abi-2 function through downstream signaling events. | ||||||